Active — Not RecruitingNot Applicable

Assessment of Platelet Rich Plasma Injection in Managing Female Patients Complaining of Mixed Urinary Incontinence (PRP)

Egypt24 participantsStarted 2024-12-28

Plain-language summary

The goal of this clinical trial is to assess the efficacy of platelet-rich plasma (PRP) for the treatment of mixed urinary incontinence determine .The main question it aims to answer whether PRP is it safe and effective in managing mixed urinary incontinence? Researchers will assess efficacy of PRP in both stress and urgency incontinence treatment Participants will: * Undergo PRP injection in to mid urethra , and installation into bladder every 1 month for 3 month * Visit the clinic once every 1 month for checkups and urodynamic study after 3 month, and 4 month after last installation

Who can participate

Age range20 Years – 60 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Women with MUI ( mild and moderate degree of stress incontinence) * Age between 20 to 60 years - Exclusion Criteria: * intrinsic sphincteric deficiency (ISD) * Pregnancy * Sepsis * Acute and chronic infections * Chronic liver disease * Anti-coagulation therapy * History of malignancy * Under anti-platelet agent treatment

What they're measuring

Number of females with treatment-related improvement of mixed urinary incontinence after receiving platelet-rich plasma (PRP) injection and instillation.

Timeframe: From enrollment to the end of intervention at 6 month "

Trial details

NCT IDNCT06769074

SponsorZagazig University

Sponsor typeOTHER_GOV

Study typeINTERVENTIONAL

Primary completion2025-06-01

View on ClinicalTrials.gov More Mixed Urinary Incontinence trials